Eli Lilly and Company (TSX: LLY.TO) Stock Competitors & Peer Comparison

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, NBLY.TO has a market cap of 835.5M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while NBLY.TO trades at CA$18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas NBLY.TO's P/E ratio is -25.48. In terms of profitability, LLY.TO's ROE is N/A, compared to NBLY.TO's ROE of -0.03%. Regarding short-term risk, LLY.TO is more volatile compared to NBLY.TO. This indicates higher risk in terms of short-term price fluctuations for LLY.TO.Check NBLY.TO's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, CYBN.NE has a market cap of 256.6M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while CYBN.NE trades at CA$10.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas CYBN.NE's P/E ratio is -2.05. In terms of profitability, LLY.TO's ROE is N/A, compared to CYBN.NE's ROE of -0.72%. Regarding short-term risk, LLY.TO is less volatile compared to CYBN.NE. This indicates lower risk in terms of short-term price fluctuations for LLY.TO.Check CYBN.NE's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, MDP.TO has a market cap of 159.6M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while MDP.TO trades at CA$5.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas MDP.TO's P/E ratio is -53.31. In terms of profitability, LLY.TO's ROE is N/A, compared to MDP.TO's ROE of -0.05%. Regarding short-term risk, LLY.TO is less volatile compared to MDP.TO. This indicates lower risk in terms of short-term price fluctuations for LLY.TO.Check MDP.TO's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, NOVC.TO has a market cap of 108M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while NOVC.TO trades at CA$1.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas NOVC.TO's P/E ratio is 34.80. In terms of profitability, LLY.TO's ROE is N/A, compared to NOVC.TO's ROE of +0.06%. Regarding short-term risk, LLY.TO is more volatile compared to NOVC.TO. This indicates higher risk in terms of short-term price fluctuations for LLY.TO.Check NOVC.TO's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, CBST.NE has a market cap of 17.5M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while CBST.NE trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas CBST.NE's P/E ratio is -0.05. In terms of profitability, LLY.TO's ROE is N/A, compared to CBST.NE's ROE of +1.07%. Regarding short-term risk, LLY.TO is more volatile compared to CBST.NE. This indicates higher risk in terms of short-term price fluctuations for LLY.TO.Check CBST.NE's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, FAF.TO has a market cap of 13.1M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while FAF.TO trades at CA$0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas FAF.TO's P/E ratio is -0.14. In terms of profitability, LLY.TO's ROE is N/A, compared to FAF.TO's ROE of -0.97%. Regarding short-term risk, LLY.TO is less volatile compared to FAF.TO. This indicates lower risk in terms of short-term price fluctuations for LLY.TO.Check FAF.TO's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, GABY.CN has a market cap of 3.7M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while GABY.CN trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas GABY.CN's P/E ratio is -0.08. In terms of profitability, LLY.TO's ROE is N/A, compared to GABY.CN's ROE of +3.03%. Regarding short-term risk, LLY.TO is more volatile compared to GABY.CN. This indicates higher risk in terms of short-term price fluctuations for LLY.TO.Check GABY.CN's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, CSCI.TO has a market cap of 2.7M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while CSCI.TO trades at CA$7.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas CSCI.TO's P/E ratio is -0.25. In terms of profitability, LLY.TO's ROE is N/A, compared to CSCI.TO's ROE of -0.93%. Regarding short-term risk, LLY.TO is less volatile compared to CSCI.TO. This indicates lower risk in terms of short-term price fluctuations for LLY.TO.Check CSCI.TO's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, IWIN.CN has a market cap of 1M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while IWIN.CN trades at CA$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas IWIN.CN's P/E ratio is -0.05. In terms of profitability, LLY.TO's ROE is N/A, compared to IWIN.CN's ROE of -0.21%. Regarding short-term risk, LLY.TO is more volatile compared to IWIN.CN. This indicates higher risk in terms of short-term price fluctuations for LLY.TO.Check IWIN.CN's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, TREE.NE has a market cap of 1M. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while TREE.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas TREE.NE's P/E ratio is -0.17. In terms of profitability, LLY.TO's ROE is N/A, compared to TREE.NE's ROE of -4.86%. Regarding short-term risk, LLY.TO is more volatile compared to TREE.NE. This indicates higher risk in terms of short-term price fluctuations for LLY.TO.Check TREE.NE's competition here

Eli Lilly and Company (TSX: LLY.TO) plays a significant role within the Healthcare sector. Its performance on the TSX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LLY.TO stands at 1.5T. In comparison, MOOD.CN has a market cap of 877.6K. Regarding current trading prices, LLY.TO is priced at CA$42.80 on the TSX, while MOOD.CN trades at CA$0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LLY.TO currently has a P/E ratio of 39.27, whereas MOOD.CN's P/E ratio is -6.03. In terms of profitability, LLY.TO's ROE is N/A, compared to MOOD.CN's ROE of -0.85%. Regarding short-term risk, LLY.TO is less volatile compared to MOOD.CN. This indicates lower risk in terms of short-term price fluctuations for LLY.TO.Check MOOD.CN's competition here